Search Results

There are 7259 results for: content related to: Idiopathic hyposmia as a preclinical sign of Parkinson's disease

  1. Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

    Annals of Neurology

    Volume 50, Issue 1, July 2001, Pages: 34–41, Henk W. Berendse, Jan Booij, Chantal M. J. E. Francot, Paul L. M. Bergmans, Ron Hijman, Johannes C. Stoof and Erik Ch. Wolters

    Article first published online : 27 APR 2001, DOI: 10.1002/ana.1049

  2. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β-CIT SPECT study

    Movement Disorders

    Volume 17, Issue 1, January/February 2002, Pages: 45–53, Walter Pirker, Schiva Djamshidian, Susanne Asenbaum, Willibald Gerschlager, Gotthard Tribl, Martha Hoffmann and Thomas Brücke

    Article first published online : 27 NOV 2001, DOI: 10.1002/mds.1265

  3. Rigidity decreases resting tremor intensity in Parkinson's disease: A [123I]β-CIT SPECT study in early, nonmedicated patients

    Movement Disorders

    Volume 16, Issue 6, November 2001, Pages: 1033–1040, Ania Winogrodzka, Robert C. Wagenaar, Paul Bergmans, Astrid Vellinga, Jan Booij, Eric A. van Royen, Richard E.A. van Emmerik, Johannes C. Stoof and Erik Ch. Wolters

    Article first published online : 7 NOV 2001, DOI: 10.1002/mds.1205

  4. Measuring the rate of progression of Parkinson's disease over a 5-year period with β-CIT SPECT

    Movement Disorders

    Volume 18, Issue 11, November 2003, Pages: 1266–1272, Walter Pirker, Iris Holler, Willibald Gerschlager, Susanne Asenbaum, Georg Zettinig and Thomas Brücke

    Article first published online : 8 JUL 2003, DOI: 10.1002/mds.10531

  5. [123I]β-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease

    Movement Disorders

    Volume 17, Issue 3, May/June 2002, Pages: 518–523, Willibald Gerschlager, Gerhard Bencsits, Walter Pirker, Bastiaan R. Bloem, Susanne Asenbaum, Daniella Prayer, Jan C.M. Zijlmans, Martha Hoffmann and Thomas Brücke

    Article first published online : 14 FEB 2002, DOI: 10.1002/mds.10092

  6. Validity of [123I]β-CIT SPECT in detecting MDMA-induced serotonergic neurotoxicity

    Synapse

    Volume 46, Issue 3, 1 December 2002, Pages: 199–205, Liesbeth Reneman, Jan Booij, Jan B.A. Habraken, Kora De Bruin, George Hatzidimitriou, Gerard J. Den Heeten and George A. Ricaurte

    Article first published online : 5 SEP 2002, DOI: 10.1002/syn.10130

  7. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  9. Enhancement of in vivo binding of [123I]β-CIT by MK-801 in rat brain

    Synapse

    Volume 30, Issue 4, December 1998, Pages: 402–408, Takayuki Nakano, Keizo Takatoku, Yoshinori Matoba, Bunichi Iwamoto, Masaru Nishiura, Osamu Inoue and Tsunehiko Nishimura

    Article first published online : 12 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199812)30:4<402::AID-SYN7>3.0.CO;2-N

  10. Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it?

    Movement Disorders

    Volume 18, Issue S7, October 2003, Pages: S43–S51, Walter Pirker

    Article first published online : 26 SEP 2003, DOI: 10.1002/mds.10579

  11. [123I]β-CIT spect in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration

    Movement Disorders

    Volume 15, Issue 6, November 2000, Pages: 1158–1167, Walter Pirker, Susanne Asenbaum, Gerhard Bencsits, Daniela Prayer, Willibald Gerschlager, Lüder Deecke and Thomas Brücke

    Article first published online : 17 JAN 2001, DOI: 10.1002/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0

  12. Fentanyl decreases β-CIT binding to the dopamine transporter

    Synapse

    Volume 29, Issue 4, August 1998, Pages: 413–415, Kim A. Bergström, Jukka Jolkkonen, Jyrki T. Kuikka, Kari K. Åkerman, Heimo Viinamäki, Olavi Airaksinen, Esko Länsimies and Jari Tiihonen

    Article first published online : 7 DEC 1998, DOI: 10.1002/(SICI)1098-2396(199808)29:4<413::AID-SYN13>3.0.CO;2-R

  13. Effect of glutamatergic systems on in vivo binding of [125I]β-CIT in the brain of a rat model of Parkinson's disease

    Synapse

    Volume 46, Issue 1, October 2002, Pages: 38–44, Shinya Kagawa, Takayuki Nakano, Osamu Inoue and Tsunehiko Nishimura

    Article first published online : 17 JUL 2002, DOI: 10.1002/syn.10096

  14. Comparative in vivo study of iodine-123-labeled β-cit and nor-β-cit binding to serotonin transporters in rat brain

    Synapse

    Volume 34, Issue 1, October 1999, Pages: 77–80, Liesbeth Reneman, Jan Booij, Jules Lavalaye, Kora De Bruin, Frederik A. De Wolff, Richard P. Koopmans, Johannes C. Stoof and Gerard J. Den Heeten

    Article first published online : 20 AUG 1999, DOI: 10.1002/(SICI)1098-2396(199910)34:1<77::AID-SYN9>3.0.CO;2-Y

  15. Role of DAT-SPECT in the diagnostic work up of Parkinsonism

    Movement Disorders

    Volume 22, Issue 9, 15 July 2007, Pages: 1229–1238, Christoph Scherfler, Johannes Schwarz, Angelo Antonini, Donald Grosset, Francesc Valldeoriola, Kenneth Marek, Wolfgang Oertel, Eduardo Tolosa, Andrew J. Lees and Werner Poewe

    Article first published online : 7 MAY 2007, DOI: 10.1002/mds.21505

  16. [123I]β-CIT SPECT demonstrates decreased brain dopamine and serotonin transporter levels in untreated parkinsonian patients

    Movement Disorders

    Volume 16, Issue 1, January 2001, Pages: 124–130, Tarja H. Haapaniemi, Aapo Ahonen, Pentti Torniainen, Kyösti A. Sotaniemi and Vilho V. Myllylä

    Article first published online : 23 JAN 2001, DOI: 10.1002/1531-8257(200101)16:1<124::AID-MDS1007>3.0.CO;2-R

  17. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease

    Synapse

    Volume 39, Issue 2, February 2001, Pages: 101–108, Jan Booij, Paul Bergmans, Ania Winogrodzka, Johannes D. Speelman and Erik Ch. Wolters

    Article first published online : 1 DEC 2000, DOI: 10.1002/1098-2396(200102)39:2<101::AID-SYN1>3.0.CO;2-1

  18. Reduced midbrain-pons serotonin transporter binding in patients with obsessive–compulsive disorder

    Acta Psychiatrica Scandinavica

    Volume 115, Issue 5, May 2007, Pages: 388–394, S. G. Hasselbalch, E. S. Hansen, T. B. Jakobsen, L. H. Pinborg, J. H. Lønborg and T. G. Bolwig

    Article first published online : 14 DEC 2006, DOI: 10.1111/j.1600-0447.2006.00940.x

  19. [123I]β-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

    Movement Disorders

    Volume 16, Issue 6, November 2001, Pages: 1023–1032, Andrea Varrone, Kenneth L. Marek, Danna Jennings, Robert B. Innis and John P. Seibyl

    Article first published online : 7 NOV 2001, DOI: 10.1002/mds.1256

  20. Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]β-CIT

    Movement Disorders

    Volume 14, Issue 3, May 1999, Pages: 436–442, Robert B. Innis, Kenneth L. Marek, Kim Sheff, Sami Zoghbi, Joseph Castronuovo, Andrew Feigin and John P. Seibyl

    Article first published online : 23 JAN 2001, DOI: 10.1002/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J